DESITIN PHARMA A/S: Financial statements 2013
CVR: 19389006
Source: annual report 2013, Danish Business Authority
01/10/2012 – 30/09/2013
DESITIN PHARMA A/S (CVR 19389006) has filed annual accounts for 2013. In 2013, the company reported a gross profit of EUR 880,963 and a net result of EUR 208,832. Equity in the 2013 report amounted to EUR 341,670. The solvency ratio was 62.9%.
- Gross Profit
- EUR 880,963
- Profit/Loss
- EUR 208,832
- Equity
- EUR 341,670
- Total Assets
- EUR 542,980
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout DESITIN PHARMA A/S
DESITIN PHARMA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Eli Lønne. The board consists of Philipp Andreas Bloching (chair), Eli Lønne and Oliver Christoph. The company is owned by Desitin Arzneimittel GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,151,761 and a net result of DKK 288,733 compared with DKK 285,567 the year before. Equity in the 2025 report amounted to DKK 7,044,140.